Skip to main
HQY

HealthEquity (HQY) Stock Forecast & Price Target

HealthEquity (HQY) Analyst Ratings

Based on 10 analyst ratings
Buy
Strong Buy 20%
Buy 70%
Hold 0%
Sell 0%
Strong Sell 10%

Bulls say

HealthEquity is the largest healthcare savings provider in the United States and has a strong position in the growing market of consumer-directed healthcare. The company has a good track record of growth and profitability, and has potential for further expansions in its total addressable market. Furthermore, HealthEquity has been investing in technology and a comprehensive healthcare solution, as well as expanding its marketplace offerings, which should continue to differentiate the company from its peers. The stock currently trades at a discount to its historical multiples, supporting a positive outlook on its future performance.

Bears say

HealthEquity is facing a number of risks, including a slow post-pandemic recovery, increasing competition, and cyber-security attacks, that could negatively impact their financial performance and outlook. In addition, the company's investment in Automation and AI is only scratching the surface on service unit costs, and their high call center expenses present a significant opportunity for automation. While regulatory tailwinds support market expansion potential, the company's recent fraud attack and lawsuit could also hinder their growth and financial performance.

HealthEquity (HQY) has been analyzed by 10 analysts, with a consensus rating of Buy. 20% of analysts recommend a Strong Buy, 70% recommend Buy, 0% suggest Holding, 0% advise Selling, and 10% predict a Strong Sell.

This aggregate rating is based on analysts' research of HealthEquity and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About HealthEquity (HQY) Forecast

Analysts have given HealthEquity (HQY) a Buy based on their latest research and market trends.

According to 10 analysts, HealthEquity (HQY) has a Buy consensus rating as of Sep 28, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $114.30, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $114.30, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

HealthEquity (HQY)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.